VBI Vaccines

$1.04 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About VBI Vaccines

VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).

Stock Analysis

last close $1.06
1-mo return 29.5%
3-mo return -14.5%
avg daily vol. 1.5M
52-week high 3.81
52-week low 0.64
market cap. $274M
forward pe -
annual div. -
roe -47.3%
ltg forecast -
dividend yield -
annual rev. $1M
inst own. 50.7%

Subscribe now for daily local and international financial news